Advanced Search
Contact | Corporate | Help

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Pancreatic Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Erlotinib
  • Drug: Capecitabine
  • Radiation: Radiation Therapy
Enrollment:
30

Additional information about NCT00614653.


SourceSolution © 2008-2012